bluebird bio
(NASDAQ:BLUE)
$6.72
At close: Aug 12
$6.96
0.2400[3.57%]
After Hours: 7:58PM EDT
Day High/Low- - -
52 Week High/Low2.87 - 10.74
Open / Close- / -
Float / Outstanding56.2M / 77.1M
Vol / Avg.- / 8M
Mkt Cap518.3M
P/E-
50d Avg. Price4.59
Div / Yield-
Payout Ratio-
EPS-1.36
Total Float56.2M

bluebird bio (NASDAQ:BLUE), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$8.00

Lowest Price Target1

$2.00

Consensus Price Target1

$4.86

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10011

Analyst Firms Making Recommendations1

  • Barclays
  • Raymond James
  • Goldman Sachs
  • Morgan Stanley
  • Cowen & Co.

1calculated from analyst ratings published within the last 6 months

Analyst Ratings for bluebird bio

All Ratings (0)

Upgrades (0)

Downgrades (0)

Initiations (0)

date
Upside/Downside
Analyst Firm
Price Target Change
Rating Change
Previous / Current Rating
Get Alert

bluebird bio Questions & Answers

Q
What is the target price for bluebird bio (BLUE)?
A

The latest price target for bluebird bio (NASDAQ: BLUE) was reported by Barclays on August 5, 2022. The analyst firm set a price target for $5.00 expecting BLUE to fall to within 12 months (a possible -25.60% downside). 16 analyst firms have reported ratings in the last year.

Q
What is the most recent analyst rating for bluebird bio (BLUE)?
A

The latest analyst rating for bluebird bio (NASDAQ: BLUE) was provided by Barclays, and bluebird bio upgraded their equal-weight rating.

Q
When is the next analyst rating going to be posted or updated for bluebird bio (BLUE)?
A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of bluebird bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for bluebird bio was filed on August 5, 2022 so you should expect the next rating to be made available sometime around August 5, 2023.

Q
Is the Analyst Rating bluebird bio (BLUE) correct?
A

While ratings are subjective and will change, the latest bluebird bio (BLUE) rating was a upgraded with a price target of $3.00 to $5.00. The current price bluebird bio (BLUE) is trading at is $6.72, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.